BACKGROUND: Attempting unhealthy weight control can be related to psychological problems such as suicidal ideations, depression, and eating disorders. Therefore, we analyzed the relationship between reduced meals for controlling weight and suicidal ideations in Korean women aged 20–40 years.METHODS: The Korean National Health and Nutrition Examination Survey is a cohort survey investigating the health behavior, chronic disease prevalence, and food and nutrition intake status of the Korean population. Ours is a cross-sectional study of 1,761 Korean women aged 20–40 years who were especially interested in weight control and who participated in the 2010–2012 Korean National Health and Nutrition Examination. We measured the percentages of smoking, drinking, educational standards, personal income, stress perception, depression, suicidal ideations, and obesity among the subjects. The participants' age and body mass index were measured as weighted means and standard errors. The relationship between reduced meals for controlling weight and suicidal ideations in Korean women aged 20–40 years was examined by logistic regression analysis.RESULTS: Of the 1,761 participants who took the survey, 642 participants experienced suicidal ideations. After making all adjustments, the odds ratio of suicidal ideations with reduced meals was 1.237 (0.588–2.602).CONCLUSION: The finding of this study revealed that there was no relationship between reduced meals for controlling weight and suicidal ideations.
Body Mass Index ; Chronic Disease ; Cohort Studies ; Cross-Sectional Studies ; Depression ; Drinking ; Eating ; Female ; Health Behavior ; Humans ; Logistic Models ; Meals ; Mental Health ; Nutrition Surveys ; Obesity ; Odds Ratio ; Prevalence ; Smoke ; Smoking ; Suicidal Ideation

Background: Nafamostat mesylate is widely used as an anticoagulant in continuous renal replacement therapy (CRRT). The generic versions of nafamostat mesylate have identical main components to the original product. However, it is questionable whether the generic versions have the same efficacy as the original. Therefore, we compared the circuit patency and exchange rates of the original nafamostat mesylate and a generic version to determine which is more efficient as an anticoagulant in CRRT. Methods: This retrospective study enrolled 1,255 patients hospitalized to receive CRRT who received the original version of nafamostat mesylate or a generic version between January 2010 and July 2018. We evaluated the filter lifespan, number of filters used per day, mean blood flow, and transmembrane pressure (TMP). Results: The mean filter lifespan was 36.3±15.1 hours in the original product group and 22.2±16.2 hours in the generic product group, which was not a statistically significant difference (p=0.060). The mean TMP was 62.2±47.3 mmHg in the original product group and 74.5±45.6 mmHg in the generic product group (p=0.045). Conclusions This retrospective study suggests no meaningful difference in filter lifespan between the original and generic versions of nafamostat mesylate. However, TMP was lower in the original product group than in the generic product group.